Our core concept is that RLS is related to an underlying problem in iron utilization. This may be specific to the brain or a region of the brain, or may be a general systemic problem with different organs having different abilities to compensate. We do not believe that there is one defect for all; rather, we believe that several problems in iron metabolism will eventually be found to contribute to this syndrome. The long-term goal of this proposal is to establish the importance of brain iron metabolism in RLS by relating changes in the CNS iron status to changes in the clinical aspects of RLS patients; and to provide improved treatment for RLS. In this grant we focus on the use of intravenous iron as a potential long-term treatment option for this syndrome. We also address the question of whether there is increased iron loss and whether there are likely to be problems of iron overload or excessive oxidative stress with iron treatment.
The specific aims of the current proposal are:
Aim 1. To evaluate the ability to sustain for 2 years the initial therapeutic benefit of 1,000 mg of IV iron with iron versus placebo """"""""supplemental"""""""" therapy.
Aim 2. To evaluate putative mechanisms behind the rapid decrease in ferritin following intravenous (IV) iron treatment of RLS patients.
Aim 3. To determine possible adverse effects from the IV iron treatment.
Aim 4. To explore the effects of supplemental IV iron on patients who are non-responders to the initial 1000-mg IV iron dose.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG021190-03
Application #
7260478
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
3
Fiscal Year
2006
Total Cost
$54,577
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Connor, James R; Patton, Stephanie M; Oexle, Konrad et al. (2017) Iron and restless legs syndrome: treatment, genetics and pathophysiology. Sleep Med 31:61-70
Allen, Richard P; Donelson, Nathan C; Jones, Byron C et al. (2017) Animal models of RLS phenotypes. Sleep Med 31:23-28
Skeba, Patrick; Hiranniramol, Kasidet; Earley, Christopher J et al. (2016) Inter-movement interval as a primary stable measure of periodic limb movements of sleep. Sleep Med 17:138-43
Allen, Richard P (2015) Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology. Sleep Med Clin 10:207-14, xi
Unger, Erica L; Bianco, Laura E; Jones, Byron C et al. (2014) Low brain iron effects and reversibility on striatal dopamine dynamics. Exp Neurol 261:462-8
Unger, E L; Jones, B C; Bianco, L E et al. (2014) Diurnal variations in brain iron concentrations in BXD RI mice. Neuroscience 263:54-9
Unger, E L; Earley, C J; Thomsen, L L et al. (2013) Effects of IV iron isomaltoside-1000 treatment on regional brain iron status in an iron-deficient animal. Neuroscience 246:179-85
Allen, Richard P; Barker, Peter B; Horsk√°, Alena et al. (2013) Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology 80:2028-34
Jellen, L C; Lu, L; Wang, X et al. (2013) Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice. Neuroscience 252:13-23
Earley, Christopher J; Kuwabara, Hiroto; Wong, Dean F et al. (2013) Increased synaptic dopamine in the putamen in restless legs syndrome. Sleep 36:51-7

Showing the most recent 10 out of 50 publications